Funding Rounds
Pheon Therapeutics

Pheon Therapeutics Series B (2024, $120M)

Pheon Therapeutics

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $120.00M

Investors